Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancer

ConclusionsOur results demonstrated that pre- and post-treatment PT-MV, as well as an at least 15% reduction in mid- to post-PT-MV, significantly correlates with OS in patients with inoperable locally advanced NSCLC.

http://link.springer.com/10.1007/s00066-017-1229-3

Source: Strahlentherapie und Onkologie - November 7, 2017 Category: Cancer & Oncology Source Type: research